FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320152854> ?p ?o ?g. }

• W4320152854 endingPage "62" @default.
• W4320152854 startingPage "55" @default.
• W4320152854 abstract "Background and Aims: On November 24, 2009, Huu S. TIEU and Golden Sunrise Pharmaceutical, Inc. (Golden Sunrise) applied for the Technology and Innovation to be reviewed and evaluated by the U.S. Food and Drug Administration (FDA). In the review and evaluation, it was requested by Golden Sunrise designated the new indications for this application under Serious or Life-threatening conditions or diseases. Discussions followed with the FDA, Huu S. TIEU, and Golden Sunrise for FDA approval on new products and new indications on existing new Medical Technology and Innovation. It was agreed in Year-2015 that the FDA would take the request for new indications to the United States Congress to establish into FDA regulation and law. At that time the following was the FDA Guidance—“Emergency Use of a Test Article” is exempt from prior Institutional Review Board or Advisory Committee evaluation and approval, provided that such emergency use is reported to the Institutional Review Board within five working days after use. Expedited Institutional Review Board or Advisory Committee approval is not permitted in emergency use. There has been no funding to the authors for the writing or publication of this article. Methods: It was requested by Huu S. TIEU and Golden Sunrise in documents given to the FDA to have Serious or Life-threatening conditions or diseases indication be recognized by law. On August 08, 2015, the FDA responding to this request took the documentation produced by Golden Sunrise to the United States Congress on behalf of Golden Sunrise and Huu S. TIEU. This article encompasses the FDA regulatory method as well as the discussion and results of the establishment of the FDA and the 21st Century Cures Act. Results: On December 13, 2016, H.R.34—114th United States Congress (2015-2016) 21st Century CURES Act was signed into law by President Barack H. Obama which included the Serious or Life-threatening indication to be written into the CURES Act. In summary, the 21st Century Cures Act is a landmark piece of legislation that enjoyed broad bipartisan support in United States Congress. The main goals of the Act are impactful and should transform future cancer, neurologic, and precision medicine or drug research as well as aid individuals with mental health is intended to facilitate the prompt approval of new agents and devices, clinicians should be aware of the types of data behind an approval and take this into consideration when developing illnesses and opioid dependence. However, some of the wording within the CURES Act regarding the drug and device approval process may bring pause to health care providers including pharmacists. Although this wording and implementing care plans and counseling patients. The 21st Century Cures Act was incorporated into laws and regulations by the FDA under § 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products." @default.
• W4320152854 created "2023-02-13" @default.
• W4320152854 creator A5023633748 @default.
• W4320152854 creator A5032808971 @default.
• W4320152854 creator A5041148504 @default.
• W4320152854 date "2022-01-01" @default.
• W4320152854 modified "2023-10-01" @default.
• W4320152854 title "Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Singed the 21st Century CURES Act into FDA Regulation and Law" @default.
• W4320152854 cites W2767488002 @default.
• W4320152854 cites W2888722353 @default.
• W4320152854 cites W4312915075 @default.
• W4320152854 cites W4312938217 @default.
• W4320152854 doi "https://doi.org/10.4236/ojrm.2022.113004" @default.
• W4320152854 hasPublicationYear "2022" @default.
• W4320152854 type Work @default.
• W4320152854 citedByCount "2" @default.
• W4320152854 countsByYear W43201528542023 @default.
• W4320152854 crossrefType "journal-article" @default.
• W4320152854 hasAuthorship W4320152854A5023633748 @default.
• W4320152854 hasAuthorship W4320152854A5032808971 @default.
• W4320152854 hasAuthorship W4320152854A5041148504 @default.
• W4320152854 hasBestOaLocation W43201528541 @default.
• W4320152854 hasConcept C127313418 @default.
• W4320152854 hasConcept C144133560 @default.
• W4320152854 hasConcept C17744445 @default.
• W4320152854 hasConcept C199360897 @default.
• W4320152854 hasConcept C199539241 @default.
• W4320152854 hasConcept C3018890749 @default.
• W4320152854 hasConcept C38262639 @default.
• W4320152854 hasConcept C41008148 @default.
• W4320152854 hasConcept C545542383 @default.
• W4320152854 hasConcept C56666940 @default.
• W4320152854 hasConcept C71924100 @default.
• W4320152854 hasConcept C91586092 @default.
• W4320152854 hasConceptScore W4320152854C127313418 @default.
• W4320152854 hasConceptScore W4320152854C144133560 @default.
• W4320152854 hasConceptScore W4320152854C17744445 @default.
• W4320152854 hasConceptScore W4320152854C199360897 @default.
• W4320152854 hasConceptScore W4320152854C199539241 @default.
• W4320152854 hasConceptScore W4320152854C3018890749 @default.
• W4320152854 hasConceptScore W4320152854C38262639 @default.
• W4320152854 hasConceptScore W4320152854C41008148 @default.
• W4320152854 hasConceptScore W4320152854C545542383 @default.
• W4320152854 hasConceptScore W4320152854C56666940 @default.
• W4320152854 hasConceptScore W4320152854C71924100 @default.
• W4320152854 hasConceptScore W4320152854C91586092 @default.
• W4320152854 hasIssue "03" @default.
• W4320152854 hasLocation W43201528541 @default.
• W4320152854 hasOpenAccess W4320152854 @default.
• W4320152854 hasPrimaryLocation W43201528541 @default.
• W4320152854 hasRelatedWork W1995515455 @default.
• W4320152854 hasRelatedWork W2080531066 @default.
• W4320152854 hasRelatedWork W2234256268 @default.
• W4320152854 hasRelatedWork W2748952813 @default.
• W4320152854 hasRelatedWork W2899084033 @default.
• W4320152854 hasRelatedWork W3031052312 @default.
• W4320152854 hasRelatedWork W3032375762 @default.
• W4320152854 hasRelatedWork W4246810794 @default.
• W4320152854 hasRelatedWork W4323056261 @default.
• W4320152854 hasRelatedWork W2520225636 @default.
• W4320152854 hasVolume "11" @default.
• W4320152854 isParatext "false" @default.
• W4320152854 isRetracted "false" @default.
• W4320152854 workType "article" @default.